Low correlation between visit-to-visit variability and 24-h variability of blood pressure

Hypertension Research

Volumn 36, Issue 11, 2013, Pages 940-946

  Muntner, Paul ^a   Shimbo, Daichi ^b   Diaz, Keith M ^b   Newman, Jonathan ^b   Sloan, Richard P ^b   Schwartz, Joseph E ^b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Columbia University ^*  (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

ambulatory blood pressure monitoring; blood pressure measurement; blood pressure variability; methods; reliability

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; PREVALENCE; RELIABILITY; SLEEP; SYSTOLIC BLOOD PRESSURE; WAKEFULNESS;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MASKED HYPERTENSION; MIDDLE AGED; OFFICE VISITS; RISK FACTORS;

EID: 84887195291     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.58     Document Type: Article

References (26)

1. Staessen JA, Beilin L, Parati G, Waeber B, White W. Task force iv: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 consensus conference on ambulatory blood pressure monitoring. Blood pressure monitoring 1999; 4: 319-331.
2. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006; 354: 2368-2374.
3. Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008; 168: 2340-2346.
4. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien EOffice versus Ambulatory Pressure Study I. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415.
5. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic hypertension in europe trial investigators. JAMA 1999; 282: 539-546
6. National institute for health and clinical excellence. Nice clinical guideline 127. Hypertension: Clinical management of primary hypertension in adults 2011.
7. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, Hodgkinson J, Mant J, Martin U, Williams B, Wonderling D, McManus RJ. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: A modelling study. Lancet 2011; 378: 1219-1230.
8. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
9. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from nhanes iii, 1988 to 1994. Hypertension 2011; 57: 160-166.
10. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-948.
11. Oparil S. New challenges in blood pressure goals and assessment. Nat Clin Pract Cardiovasc Med 2011; 8: 1-2.
12. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Bjorklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA. Prognostic value of reading-to-reading blood pressure variability over 24 h in 8938 subjects from 11 populations. Hypertension 2010; 55: 1049-1057.
13. International Expert C. International expert committee report on the role of the a1c assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-1334.
14. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association council on high blood pressure research. Hypertension 2005; 45: 142-161.
15. Muntner P, Joyce C, Levitan EB, Holt E, Shimbo D, Webber LS, Oparil S, Re R, Krousel-Wood M. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens 2011; 29: 2332-2338.
16. Bilo G, Giglio A, Styczkiewicz K, Caldara G, Maronati A, Kawecka-Jaszcz K, Mancia G, Parati G. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens 2007; 25: 2058-2066.
17. Mena L, Pintos S, Queipo NV, Aizpurua JA, Maestre G, Sulbaran T. A reliable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23: 505-511.
18. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977; 33: 363-374.
19. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27: 130-135.
20. Grove JS, Reed DM, Yano K, Hwang LJ. Variability in systolic blood pressure-a risk factor for coronary heart disease? Am J Epidemiol 1997; 145: 771-776.
21. Hsieh YT, Tu ST, Cho TJ, Chang SJ, Chen JF, Hsieh MC. visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: A 5.5-year prospective analysis. Eur J Clin Invest 2012; 42: 245-253.
22. Mancia G, Facchetti R, Parati G, Zanchetti A. visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens 2012; 30: 1241-1251.
23. Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K. visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012; 25: 962-968.
24. Mancia G. Short-and long-term blood pressure variability: Present and future. Hypertension 2012; 60: 512-517.
25. Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, Emdin M, Flacco M, Schillaci G, De CR. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res 2008; 31: 2137-2146.
26. Diaz KM, Veerabhadrappa P, Kashem MA, Feairheller DL, Sturgeon KM, Williamson ST, Crabbe DL, Brown MD. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in african americans. Hypertens Res 2012; 35: 55-61.